Shannon Wilson

Shannon Wilson is a clinical operations professional with 25 years of experience in the pharmaceutical/biotechnology industry and 17 years as the head of clinical operations.

Prior to joining Faraday in April 2019, Ms. Wilson served as Vice President Clinical Operations for Nohla Therapeutics, Inc. from 2017 to 2019 studying an allogeneic cell therapy and as Executive Director, Clinical Operations at Raptor Pharmaceuticals Corp. from 2015 to 2017 executing trials for rare diseases. She also worked for Dendreon Corporation from 2001 to 2015, most recently as Senior Director of Clinical Operations, developing the first FDA-approved immunotherapy made from a patient’s own immune cells. She received her Bachelor’s Degree in Biology from Washington State University.